BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28782737)

  • 1. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.
    Gasparrini S; Cimadamore A; Scarpelli M; Massari F; Doria A; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montironi R
    Asian J Androl; 2017 Aug; 21(1):19-23. PubMed ID: 28782737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer: from Gleason scoring to prognostic grade grouping.
    Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
    Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
    Montironi R; Cheng L; Cimadamore A; Mazzucchelli R; Scarpelli M; Santoni M; Massari F; Lopez-Beltran A
    Transl Androl Urol; 2021 Mar; 10(3):1530-1540. PubMed ID: 33850787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Gleason grading and novel Grade Groups in clinical practice.
    Magi-Galluzzi C; Montironi R; Epstein JI
    Curr Opin Urol; 2016 Sep; 26(5):488-92. PubMed ID: 27308734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving Gleason grading system.
    Chen N; Zhou Q
    Chin J Cancer Res; 2016 Feb; 28(1):58-64. PubMed ID: 27041927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
    Epstein JI; Zelefsky MJ; Sjoberg DD; Nelson JB; Egevad L; Magi-Galluzzi C; Vickers AJ; Parwani AV; Reuter VE; Fine SW; Eastham JA; Wiklund P; Han M; Reddy CA; Ciezki JP; Nyberg T; Klein EA
    Eur Urol; 2016 Mar; 69(3):428-35. PubMed ID: 26166626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of the Gleason grading system.
    Epstein JI
    J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
    Epstein JI; Allsbrook WC; Amin MB; Egevad LL
    Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in prostate cancer pathology: Gleason grading and beyond.
    Shah RB; Zhou M
    Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tertiary Gleason pattern in the contemporary era of Gleason grade grouping: A narrative review.
    Taguchi S; Morikawa T; Shibahara J; Fukuhara H
    Int J Urol; 2021 Jun; 28(6):614-621. PubMed ID: 33580599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives on the Gleason grading of prostate cancer.
    Shah RB
    Arch Pathol Lab Med; 2009 Nov; 133(11):1810-6. PubMed ID: 19886716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system.
    Shah RB; Tadros Y
    Hum Pathol; 2014 Nov; 45(11):2263-9. PubMed ID: 25228336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.
    Kryvenko ON; Epstein JI
    Arch Pathol Lab Med; 2016 Oct; 140(10):1140-52. PubMed ID: 26756649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy.
    Lilleby W; Torlakovic G; Torlakovic E; Skovlund E; Fosså SD
    Cancer; 2001 Jul; 92(2):311-9. PubMed ID: 11466684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade.
    Zelic R; Giunchi F; Fridfeldt J; Carlsson J; Davidsson S; Lianas L; Mascia C; Zugna D; Molinaro L; Vincent PH; Zanetti G; Andrén O; Richiardi L; Akre O; Fiorentino M; Pettersson A
    Clin Epidemiol; 2022; 14():59-70. PubMed ID: 35082531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.